Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
Last trade$1.08
Day change-$0.01 (-0.92%)
Day range$1.00 – $1.10
Volume11,527
Market cap$9M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for BON.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for BON.
Recent news
Company coverage with links to the original publishers.
U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Investors will keep an eye on the Federal Reserve's decision on interest rates this week. Analysts say any de-escalation in trade tensions should be positive for the economy and financial markets.
BON, a bio-ingredient solution provider, announced a patent-pending technology that enhances the bioavailability of glucoraphanin, a key compound in broccoli. This breakthrough aims to improve the conversion of glucoraphanin to sulforaphane, which has diverse health benefits.
Univest Securities, LLC announced the closing of a $12 million best efforts offering for its client Bon Natural Life Limited (BON), a bio-ingredient solutions provider. The company plans to use the proceeds for sales network expansion, R&D, production capacity expansion, and general corporate purposes.
U.S. stock futures were flat on Tuesday as investors remained cautious ahead of the FOMC meeting. Analysts say the only certainty is that 'things will remain uncertain for the time being'.